Articles related to MEDICARE

PBMs’ vertical integration allows them to dictate cancer treatment decisions, from drug selection to delivery methods, potentially compromising patient care and increasing costs.

The inclusion of Medicare Advantage data and increased emphasis on patient outcomes in the US News Best Hospitals rankings further illustrates the growing importance of comprehensive, coordinated care in today’s healthcare landscape.

Vertical consolidation in healthcare raises concerns about corporatization pitting profit maximization against physicians’ ethical obligations to prioritize patient interests.

Higher telehealth use correlates with increased healthcare utilization and costs, indicating that while telehealth improves access, it may also lead to higher rates of ambulatory care-sensitive hospitalizations.

Oncology practitioners have a new opportunity to ethically enhance their E/M billing through Medicare’s code G2211, which emphasizes the value of sustained care and complexity in patient management.

The Inflation Reduction Act’s out-of-pocket cap on Medicare Part D spending marks a pivotal shift in healthcare economics, potentially altering prescription drug cost dynamics for millions of enrollees. Physicians should be aware of these changes to better support and inform their patients navigating these new financial landscapes.